SALIVARY PHENYTOIN CONCENTRATIONS IN EPILEPSY AND IN CHRONIC RENAL FAILURE
- 1 August 1976
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 308 (7982), 384-386
- https://doi.org/10.1016/s0140-6736(76)92404-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- ONE DRUG (PHENYTOIN) IN THE TREATMENT OF EPILEPSYThe Lancet, 1976
- SERUM-PHENYTOIN LEVELS IN MANAGEMENT OF EPILEPSYThe Lancet, 1975
- Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patientsEuropean Journal of Clinical Pharmacology, 1975
- Anticonvulsant Effect of Diphenylhydantoin Relative to Plasma LevelsArchives of Neurology, 1974
- Usefulness of Blood Levels of Antiepileptic DrugsArchives of Neurology, 1974
- Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbitalClinical Pharmacology & Therapeutics, 1974
- Plasma protein binding of diphenylhydantoin Effects of sex hormones, renal and hepatic diseaseClinical Pharmacology & Therapeutics, 1974
- Protein Binding of Diphenylhydantoin and Desmethylimipramine in Plasma from Patients with Poor Renal FunctionNew England Journal of Medicine, 1971
- ABNORMAL PHARMACOKINETICS OF PHENYTOIN IN A PATIENT WITH URÆMIAThe Lancet, 1970
- Clinical and Electroencephalographic Correlations with Serum Levels of DiphenylhydantoinArchives of Neurology, 1960